JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JCM.01981-07v1
46/2/740    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Allan, B.
Right arrow Articles by Williamson, A.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Allan, B.
Right arrow Articles by Williamson, A.-L.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, February 2008, p. 740-742, Vol. 46, No. 2
0095-1137/08/$08.00+0     doi:10.1128/JCM.01981-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Cervical Human Papillomavirus (HPV) Infection in South African Women: Implications for HPV Screening and Vaccine Strategies{triangledown}

Bruce Allan,1 Dianne J. Marais,1 Margaret Hoffman,2 Samuel Shapiro,2 and Anna-Lise Williamson1,3*

Institute of Infectious Disease and Molecular Medicine and Division of Medical Virology, Department of Clinical Laboratory Sciences, Faculty of Health Sciences, University of Cape Town, Observatory, Cape Town, South Africa,1 School of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town, Observatory, Cape Town, South Africa,2 National Health Laboratory Service, Groote Schuur Hospital, Observatory, Cape Town, South Africa3

Received 8 October 2007/ Accepted 17 October 2007

The prevalence of cervical human papillomavirus (HPV) in South African women (n = 1,073) increased from 20.4% (173/848) in women with normal cytology to 41.7% (48/115) in women with atypical squamous cells of undetermined significance, 70.2% (40/57) in women with low-grade squamous intraepithelial lesions, and 83% (44/53) in women with high-grade squamous intraepithelial lesions (HSILs). HPV types 16 and 35 were the dominant types in women with HSILs but not in women in the other categories.

* Corresponding author. Mailing address: Institute of Infectious Disease and Molecular Medicine and Division of Medical Virology, Department of Clinical Laboratory Sciences, Faculty of Health Sciences, University of Cape Town, Anzio Road, Observatory, Cape Town 7925, South Africa. Phone: 27 21 4066124. Fax: 27 21 4066681. E-mail: anna-lise.williamson{at}uct.ac.za

{triangledown} Published ahead of print on 31 October 2007.

Journal of Clinical Microbiology, February 2008, p. 740-742, Vol. 46, No. 2
0095-1137/08/$08.00+0     doi:10.1128/JCM.01981-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.